Tags : Research

DIA India Medical Devices Conference from 21-22 February 2020 I

The Medical Devices Conference hosted by DIA India on 21st and 22nd February in collaboration with Medical Technology Association of India (MTaI), AIC-AMTZ Medivalley Incubation Council and mDI Europa, is one of the largest gatherings of medical devices professionals in the region. This initiative is a first for DIA in India and holds promise to […]Read More

­WHO to Accelerate Global Research and Innovation Against Corona Virus

Shots: WHO convoke global research and innovation forum to be held on Feb 11-12, 2020 in Geneva for mobilization of international action in response to the coronavirus (2019-nCoV) and is organized in collaboration with the Global Research Collaboration for Infectious Disease Preparedness The forum will involve scientist, public health agencies, ministries of health and research […]Read More

Accenture Collaborates with Google Cloud to Support Life Sciences Companies

Shots: Google Cloud will be the technology provider for Accenture’s current and future solutions that is a part of its INTIENT life sciences industry platform. The collaboration is an extension of the partnership between the companies built over the last 8yrs. The collaboration will combine Google’s cloud and AI capabilities with Accenture’s life science capabilities, […]Read More

Roche Signs an AI-Based Research Agreement with Sensyne Health

Shots: Roche and Sensyne Health collaborate to apply AI technology for clinical trial designs and will further strengthen Roche’s approach in data and technology-driven personalized healthcare The collaboration will focus on identifying patient’s population in one disease and further assessing and collating anonymized patient data with anonymized EHR data for supporting clinical trial planning In […]Read More

Pfizer Extends its Research and License Agreement with BioInvent to

Shots: Pfizer has selected its second target under the research and license agreement signed by the companies in 2016 and has extended the research term by six months BioInvent to receive $0.3M as target fees and will get milestones for the development of Ab directed against the target and is eligible to receive further milestones […]Read More

Eisai Signs a Research Collaboration with BioArctic to Characterize BAN2401’s

Shots: Eisai and BioArctic collaborate to further characterize the MOA of BAN2401. Earlier in 2005, the companies partnered for the therapy targeting Alzheimer’s disease and later in 2007, BioArctic licensed BAN2401 to Eisai Under the research collaboration, BioArctic will receive $3.89M from Eisai and is expected to continue the collaboration through the end of Jun’2021 […]Read More

Regeneron Signs a Research and Option to License Agreement with

Shots: Vyriad to receive upfront, development and commercial milestone payments based on certain achievements and royalties on sales of products. Regeneron to get an exclusive option to license Vyriad’s Voyager-V1 plus other products and will make equity investment in Vyriad The agreement also includes a P-II clinical study assessing Regeneron’s Libtayo (cemiplimab-rwlc) + Vyriad’s oncolytic […]Read More

Takeda Signs an Exclusive License and Research Agreement with MD

Shots: Takeda to get rights to develop and commercialize up to four programs including a CD19-targeted CAR NK-cell therapy and a B-cell maturation antigen (BCMA)-targeted CAR NK-cell therapy and will also have rights to access MD Anderson’s CAR NK platform MD Anderson to get upfront payment and is eligible to receive development and commercial milestones […]Read More

Bluebird Bio Signs a Three-Year Research Collaboration with Novo Nordisk

Shots: Bluebird Bio to utilize its mRNA-based megaTAL technology providing a specific and efficient way to silence, edit or insert genetic components combining Novo Nordisk’s deep expertise in hemophilia research and therapeutics  The focus of the collaboration is to identify gene therapy candidates for people with severe genetic diseases with initial interest of correcting FVIII-clotting […]Read More